| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |